Skip to main content

You are using an old and unsupported browser. Most core functionality will not work. Please upgrade to a supported browser - Google Chrome

CICM 2021 VIRTUAL ASM | RESPIRATORY
CICM 2021 ASM: Respiratory
CICM 2021 VIRTUAL ASM | RESPIRATORY
Home
Times are shown in your local time zone GMT
User Headshot

Prof John F Fraser

Director Critical Care Research Group at The Prince Charles Hospital and University of Queensland, and Director of the Intensive Care Unit at St Andrew’s War Memorial Hospital.

Rating


Professional Bio

Prof John Fraser (MB ChB, PhD, FRCP(Glas), FFARCSI, FRCA, FCICM) is the Director of the Critical Care Research Group at The Prince Charles Hospital and University of Queensland, and Director of the Intensive Care Unit at St Andrew’s War Memorial Hospital.
 
Following his PhD in fetal wound healing, John started the Critical Care Research Group at Australia’s largest cardiac centre - The Prince Charles Hospital. The Group has now developed to almost 90 staff and 8 labs.  Being awarded the first international Centre for Research Excellence in mechanical support the CCRG has become popular with over 25 nationalities represented.  John is also President of APELSO and Chair of the Queensland Cardiovascular Research Network.
 
John’s extensive global network has helped facilitate the birth of the COVID Consortium, the largest Critical Care community using Artificial Intelligence with colleagues from 54 countries around the world during the COVID-19 Pandemic.  Working with over 370 world leading hospitals across the globe John has brought in leaders in AI, Amazon and IBM to accelerate data ingestion. The COVID-19 consortium tool kit developed with Amazon allows data ingestion using visual and audio input. The dashboard, developed by the University of Queensland and augmented by IBM, updates in real time to allow decision support at the bedside. The world leading Journal of American Medical Association hailed this quantum change and highlighted how it may change the process of clinical research not just during the COVID-19 crisis but well into the future in many fields of medicine. 
 
Having noticed a critical funding gap to transport early to mid-stage innovations through to manufacture and commercialisation John has founded De Motu Cordis - an emergency drug delivery device and co-founded the Quantum Medical Innovation Fund, focussing on medical innovations. 
 
Prof Fraser continues to push at the boundaries of medicine, science and technology.